Get the Stockscreener App
17.32
1.76%
0.30
After Hours:
17.22
-0.10
-0.58%
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $17.32, with a volume of 34.67M.
It is up +1.76% in the last 24 hours and up +3.28% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
See More
Previous Close:
$17.02
Open:
$17
24h Volume:
34.67M
Relative Volume:
0.87
Market Cap:
$33.18B
Revenue:
$15.14B
Net Income/Loss:
$1.42B
P/E Ratio:
23.53
EPS:
0.7361
Net Cash Flow:
$1.63B
1W Performance:
+2.06%
1M Performance:
+3.28%
6M Performance:
-19.52%
1Y Performance:
-23.83%
1-Day Range:
$16.98
$17.35
1-Week Range:
$16.70
$17.35
52-Week Range:
$14.02
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
17.32 | 32.61B | 15.14B | 1.42B | 1.63B | 0.7361 |
|
PG
Procter Gamble Co
|
139.82 | 326.28B | 84.93B | 16.86B | 14.94B | 6.8506 |
|
UL
Unilever Plc Adr
|
63.86 | 139.57B | 64.99B | 6.71B | 6.53B | 2.4355 |
|
CL
Colgate Palmolive Co
|
77.76 | 62.05B | 20.10B | 3.04B | 3.44B | 3.569 |
|
EL
Estee Lauder Cos Inc
|
107.28 | 36.99B | 14.42B | -930.00M | 1.05B | -2.5832 |
|
KMB
Kimberly Clark Corp
|
103.14 | 34.14B | 18.08B | 1.81B | 1.67B | 5.904 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kimberly-Clark Reaches For Kenvue: Life-Saving Hand Or Capitalizing On Weakness? (KVUE) - Seeking Alpha
Kenvue Inc. $KVUE Shares Sold by State Street Corp - MarketBeat
Natixis Buys 96,644 Shares of Kenvue Inc. $KVUE - MarketBeat
Bank of Nova Scotia Buys 460,562 Shares of Kenvue Inc. $KVUE - MarketBeat
GS Equity Income Fund: Q3 2025 Witnesses Fundamental Strength And Expansive Margin Opportunities - Seeking Alpha
Texas Attorney General Ken Paxton Secures TRO Against Johnson & - Hoodline
Texas Granted TRO Against Kenvue, Johnson & Johnson for Alleged Unregistered Foreign Company Status - thetexan.news
California Public Employees Retirement System Has $67.86 Million Position in Kenvue Inc. $KVUE - MarketBeat
Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Investing News Network
Paxton Secures Major Win Against Johnson & Johnson and Kenvue - Texas Border Business
Kenvue and J&J must register in Texas or face business ban, judge rules - Investing.com Nigeria
Texas AG Secures Restraining Order Against J&J, Kenvue Over Alleged Business Registration Violations - Dallas Express
Tylenol Maker Isn’t Registered to Operate in Texas, Judge Says - Bloomberg.com
P/E Ratio Insights for Kenvue - Benzinga
Kenvue Inc. $KVUE Position Raised by Ossiam - MarketBeat
Kenvue (KVUE): Assessing Valuation After Steady Earnings Growth and Weak One-Year Share Price Returns - Yahoo Finance
Macquarie Value Fund Q3 2025 Contributors And Detractors - Seeking Alpha
Motley Fool: Kimberly-Clark is getting bigger and bigger - The Spokesman-Review
Federated Hermes Inc. Grows Holdings in Kenvue Inc. $KVUE - MarketBeat
The Motley Fool: Kimberly-Clark is growing - Dallas News
Guggenheim Capital LLC Raises Stock Position in Kenvue Inc. $KVUE - MarketBeat
Institution Moves: Can Kenvue Inc stock hit record highs againMarket Movers & Consistent Profit Focused Trading Strategies - BỘ NỘI VỤ
Kenvue Inc. $KVUE Shares Bought by Burgundy Asset Management Ltd. - MarketBeat
Brown Advisory Inc. Cuts Position in Kenvue Inc. $KVUE - MarketBeat
Baird Financial Group Inc. Has $16.35 Million Stake in Kenvue Inc. $KVUE - MarketBeat
What's the Deal With Kimberly Clark's Acquisition of Kenvue? - Nasdaq
Invesco Ltd. Has $372.95 Million Stock Position in Kenvue Inc. $KVUE - MarketBeat
CW Advisors LLC Has $5.30 Million Stock Position in Kenvue Inc. $KVUE - MarketBeat
Amundi Has $305.45 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
The New York Stock Exchange | NYSE - NYSE
Kenvue: Worth Owning As Kimberly-Clark Deal Plays Out (NYSE:KVUE) - Seeking Alpha
Option traders moderately bearish in Kenvue Inc with shareslittle changed - TipRanks
Kenvue Stock: Is KVUE Underperforming the Consumer Defensive Sector? - Barchart.com
Mirabella Financial Services LLP Trims Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Quantbot Technologies LP Acquires Shares of 144,914 Kenvue Inc. $KVUE - MarketBeat
Does Kenvue Inc. stock trade below intrinsic valueLayoff News & Smart Allocation Stock Reports - Newser
Epoch Investment Partners Inc. Sells 486,365 Shares of Kenvue Inc. $KVUE - MarketBeat
How geopolitical tensions affect Kenvue Inc. stockJuly 2025 Recap & AI Powered Market Trend Analysis - Newser
How Kenvue Inc. (J4D) stock compares with top peersExit Point & Verified High Yield Trade Plans - Newser
Kenvue (KVUE) Valuation Check as Strategic Review Targets Portfolio Realignment and Higher-Margin Growth - simplywall.st
Kenvue Inc. (KVUE): A Bull Case Theory - Finviz
Will Kenvue Inc. stock outperform small cap peersBear Alert & Daily Stock Trend Watchlist - Newser
The 10 Best Dividend Stocks - Morningstar
[Form 4] Kenvue Inc. Insider Trading Activity - Stock Titan
Kenvue (NYSE: KVUE) director reports 1,451 DSUs, total 13,641.878 units - Stock Titan
Kenvue (KVUE) General Counsel Form 4 shows RSU conversion and tax share withholding - Stock Titan
Kenvue (NYSE: KVUE) executive Form 4 shows RSU vesting and 58K shares owned - Stock Titan
Kenvue (NYSE: KVUE) COO converts RSUs, withholds shares for taxes - Stock Titan
Kenvue (NYSE: KVUE) director now holds 35,906 deferred share units - Stock Titan
Kenvue (KVUE) Chief People Officer reports RSU vesting, 731 shares withheld at $17.22 - Stock Titan
Kenvue (KVUE) Chief Scientific Officer reports RSU vesting and share withholding - Stock Titan
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):